SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-15-000021
Filing Date
2015-06-05
Accepted
2015-06-05 17:30:20
Documents
1
Period of Report
2015-06-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 12260
  Complete submission text file 0000891293-15-000021.txt   13712
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3101 WESTERN AVENUE, SUITE 600 SEATTLE WA 98121
Business Address
Plunkett Matthew (Reporting) CIK: 0001557551 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 15916854